Dana Reyes
Features Writer
Women 35–50 dealing with perimenopause, weight, hormones and stress
Dana Reyes writes features on the real science of perimenopause, metabolism and stress for women juggling everything at once. She specializes in separating what the evidence supports from what's just good marketing.
Latest articles
The Cardiometabolic Continuum: Why Inflammation Is Becoming the New Vital Sign
Endocrinologists are quietly rewriting the rulebook — treating diabetes, fatty liver, and heart disease as one slow-burning inflammatory story. Here's what that means for the rest of us.
The Quiet Number on Your Bloodwork That May Predict More Than You Think
A new NHANES analysis suggests a simple index pulled from a routine CBC — the Systemic Immune-Inflammatory Index — tracks with mortality risk in metabolic syndrome. Here's what it is, and what it isn't.
Hidden Cholesterol: Why a 'Normal' Total Score Misses the LDL That Matters
Two new population studies suggest the cholesterol number on your lab slip may be quietly underselling your real cardiovascular risk — especially if you're carrying belly weight or creeping insulin resistance.
The TyG Index: A Cheap Lab-Math Trick That May Flag Future Heart-Valve Trouble
A 40,000-person Chinese cohort found that a number you can calculate from a routine lipid panel tracks with incident aortic valve calcification — and inflammation explains part of the link.
The Metabolic Syndrome Map: What a New Global Snapshot Reveals About Your Risk
A 2026 meta-analysis pools a decade of evidence on how common metabolic syndrome has become — and how much of it tracks back to the lifestyle levers we actually control.
The Gut Microbe That Turns Dietary Fat Into an Appetite Brake
A common gut bacterium called Blautia wexlerae appears to rewrite dietary fats into signals that nudge GLP-1 release. The science is early — but the mechanism is genuinely new.
Tirzepatide vs. Semaglutide: What the Head-to-Head Data Actually Shows
A new meta-analysis pooling seven direct comparisons gives us the cleanest apples-to-apples read yet on how the two big incretin drugs stack up for weight loss.
GLP-1 Nation: What the First Federal Tally of Injectable Use Reveals About America's Metabolic Moment
A new federal survey puts a real number on how many Americans with diabetes are now on GLP-1 shots — and it's reshaping what we should expect from the next wave of metabolic drugs.
Your Flu Shot Might Also Be Heart Medicine: What a New Cardiology Consensus Says
Two Taiwanese medical societies just published joint guidelines reframing routine vaccines — flu, pneumococcal, shingles, COVID — as underused tools for preventing heart attacks and strokes in high-risk adults.
What Smoking Still Costs Your Eyes — A New Meta-Meta-Analysis Quantifies the Damage
A synthesis of 16 systematic reviews puts hard numbers on a soft truth: the cleanest longevity move you can make for your vision is still to quit.
The Brain Pollution Bombshell: Could Alzheimer's and Parkinson's Really Begin in Childhood?
A provocative review of brain tissue from young Mexico City residents argues that ultrafine air pollution may seed neurodegeneration decades before symptoms appear. The evidence is moderate — but hard to unsee.
Clonal Hematopoiesis: The Silent Aging Mutation Showing Up on Routine Blood Work
A quiet genetic shift called CHIP is turning up more often as we age — and researchers are connecting it to heart and blood disease. Here's what the evidence actually says.